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Noradrenergic ﬁbers innervate the entire cerebral cortex, whereas the cortical distribution
of dopaminergic ﬁbers is more restricted. However, the relative functional impact of
noradrenalin and dopamine receptors in various cortical regions is largely unknown. Using
a speciﬁc genetic label, we ﬁrst conﬁrmed that noradrenergic ﬁbers innervate the entire
cortex whereas dopaminergic ﬁbers were present in all layers of restricted medial and
lateral areas but only in deep layers of other areas. Imaging of a genetically encoded sensor
revealed that noradrenalin and dopamine widely activate PKA in cortical pyramidal neurons
of frontal, parietal and occipital regions with scarce dopaminergic ﬁbers. Responses to
noradrenalin had higher amplitude, velocity and occurred at more than 10-fold lower dose
than those elicited by dopamine, whose amplitude and velocity increased along the antero-
posterior axis.The pharmacology of these responses was consistent with the involvement
of Gs-coupled beta1 adrenergic and D1/D5 dopaminergic receptors, but the inhibition of
both noradrenalin and dopamine responses by beta adrenergic antagonists was suggestive
of the existence of beta1-D1/D5 heteromeric receptors. Responses also involved Gi-
coupled alpha2 adrenergic and D2-like dopaminergic receptors that markedly reduced their
amplitude and velocity and contributed to their cell-to-cell heterogeneity. Our results reveal
that noradrenalin and dopamine receptors both control cAMP-PKA signaling throughout the
cerebral cortex with moderate regional and laminar differences. These receptors can thus
mediate widespread effects of both catecholamines, which are reportedly co-released by
cortical noradrenergic ﬁbers beyond the territory of dopaminergic ﬁbers.
Keywords: catecholamines, GPCR, protein kinase A, imaging, cerebral cortex
INTRODUCTION
The catecholamines dopamine (DA) and noradrenalin (NA) are
neurotransmitters that widely modulate brain circuits and behav-
iors. NA is involved in arousal, attention, memory, and stress
whereas DA is implicated in learning, reward, attention, and
movement control. Likewise, catecholaminergic dysfunctions are
associated with cognitive, emotional, and motor disorders and
catecholaminergic transmission is the target of multiple drugs
used in therapy of human brain disorders. Catecholamines are
synthesized in discrete brainstem nuclei via a common pathway
involving tyrosine hydroxylase (TH) that leads to DA production,
which is converted to NA by DA beta hydroxylase (DBH). The
effects of DA and NA are mediated by G protein-coupled recep-
tors. The ﬁve DA receptors belong to the D1/D5 or D2-like classes,
which activate or inhibit cAMP/protein kinase A (PKA) signal-
ing via Gs or Gi proteins, respectively (Beaulieu and Gainetdinov,
2011). NA also regulates the cAMP/PKApathway by activatingGs-
coupled beta1–3 receptors or Gi-coupled alpha2 adrenoceptors.
NA additionally activates the phospholipase C pathway through
Gq-coupled alpha1 receptors (Bylund, 1992; Cotecchia, 2010;
Evans et al., 2010).
Dopamine- and NA-containing ﬁbers exhibit wide, but distinc-
tive, distributions in the brain. Catecholaminergic projections to
the cerebral cortex stem from DA neurons of the ventral tegmen-
tal area (VTA) and NA neurons of the locus coeruleus (LC). LC
ﬁbers innervate the entire cortical mantle, whereas VTA ﬁbers dis-
tribute in all layers of medio-frontal and ventro-lateral cortices,
but are restricted to deep layers in other areas of the rodent cor-
tex (Morrison et al., 1978, 1979; Descarries et al., 1987; Berger
et al., 1991; Latsari et al., 2002). The broad distribution of NA
receptors in the rodent cortex is consistent with that of LC ﬁbers
(Nicholas et al., 1996; Venkatesan et al., 1996; Papay et al., 2006;
Paschalis et al., 2009). In contrast, a mismatch exists between the
widespread expression also reported for DA receptors (Ariano and
Sibley, 1994; Khan et al., 1998; Luedtke et al., 1999; Lemberger
et al., 2007; Rivera et al., 2008; Oda et al., 2010), and the restricted
distribution of VTA ﬁbers in the rodent cortex. While LC ﬁbers are
a plausible source of cortical DA outside the VTA projection areas
(Devoto et al., 2005, 2008), the question of the relative functional
impact of DA and NA receptors in various cortical regions has not
been addressed.
In the present study, we ﬁrst examined the distribution of
LC and VTA ﬁbers in the rodent cortex using site and cell-
type-speciﬁc labeling of catecholaminergic neurons with green
ﬂuorescent protein (GFP) via conditional viral transfer. We then
characterized the functional impact of Gs- and Gi-coupled DA
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and NA receptors on cAMP/PKA signaling in layers II/III and
V of the frontal, parietal, and occipital cortex using 2-photon
imaging of a genetically encoded PKA sensor in rat brain slices
(Bonnot et al., 2014). Our results conﬁrm the differential dis-
tribution of LC and VTA ﬁbers in the cortex and reveal that
both NA and DA receptors control cAMP-PKA signaling through-




All the experiments were performed according to the guide-
lines of the French Ministry of Agriculture, Food Processing
Industry and Forestry for handling animals (decree 2013-118).
Transgenic DBH-Cre mice (DBH-cre) were a gift from Bruno
Giros [McGill University, Canada, MMRRC line: Tg(Dbh-cre)
KH212Gsat/Mmucd, stock number 032081-UCD (Gong et al.,
2007)]. DA transporter-Cre mice (DAT-cre) were a gift from Uwe
Maskos [Institut Pasteur, France, (Tg)BAC-DATiCrefto (Turiault
et al., 2007)]. Male Wistar rats (12–15 days old) were obtained
from Janvier Labs. Animals were maintained in a 12 h light–12 h
dark cycle, in stable conditions of temperature (22◦C), with food
and water available ad libitum.
AAV PRODUCTION AND STEREOTACTIC INJECTION
Site- and cell-type-speciﬁc labeling of NA or DA neurons was
achieved by stereotactic injection of a viral vector into the LC of
DBH-Cre or theVTAof DAT-Cremice (1–3month-old). The viral
vector was a recombinant adeno-associated virus (AAV) driving
Cre-dependent expression of a fusion protein containing channel-
rhodopsin 2 (ChR2) and a yellow variant (YFP) of the GFP from
Aequorea victoria. The Cre-inducible vector AAV2/1-EF1a-DIO-
hChR2(H134R)-EYFP-WPRE-HGHpA (titer: 3× 1011 gc/ml)was
produced from Addgene plasmid #20298 at the vector core facil-
ity of Nantes University (UMR 1089 IRT1, France). Aliquots of
the pseudovirion were stored at −80◦C before stereotactic injec-
tion. Mice (six DAT-Cre and six DBH-Cre) were anesthetized
with isoﬂurane and placed on a small animal stereotactic frame.
For transduction of LC NA neurons, AAV-EF1α-DIO-ChR2-
YFP pseudovirion was bilaterally injected adjacent to the LC
at coordinates from bregma: antero-posterior (AP), −5.45 mm;
medio-lateral (ML), ±1 mm; dorso-ventral (DV) −3.65 mm).
ForDAneuron transduction, pseudovirionwas bilaterally injected
into the VTA (AP: −3.4 mm, ML: ±0.5 mm, DV: −4.4 mm).
Injections were performed through an internal canula at a rate
of 0.1 μl/min for 10 min (total 1 μl per site). The can-
ula was held in place for 15 min before retraction out of the
brain.
IMMUNOHISTOCHEMISTRY
Eight weeks after injection, mice were deeply anesthetized with
10 mg/ml ketamine and 0.1% xylazine before transcardiac perfu-
sion with 50 ml of 4% paraformaldehyde in 0.12 mM phosphate
buffer (pH 7.4). Brains were removed and post-ﬁxed with the
same solution for 2 h, cryoprotected with 30% sucrose and cut
with a freezing microtome (Leica) at a thickness of 40 μm. Slices
were washed overnight with PBS, then blocked and permeabilized
with PBS complemented with 0.2% ﬁsh skin gelatin, 0.25% tri-
ton X-100 (PBS-GT) for 2 h at room temperature. Brain slices
were incubated overnight at 4◦C with primary antibody diluted
in PBS-GT (monoclonal mouse anti TH: MAB318 (Clone LNC1),
Millipore, 1/2000; polyclonal chicken anti-GFP: GFP-1020 (Aves
Labs, 1/2000). After 6 ×10 min washes in PBS-GT, slices were
incubated for 3 h at room temperature with ﬂuorescently labeled
secondary antibodydiluted at 1/1000 inPBS-GT (goat anti chicken
alexa488, Invitrogen A11039; goat anti mouse Alexa555, Invitro-
gen A21422). Slices were mounted in ﬂuoromount (Clinisciences)
after extensive washes in PBS-GT followed by PBS. Images were
obtained using an AXIO Zoom.V16 macroscope (Zeiss). Labeled
ﬁbers were drawn in black (value of the pixel: 255) on white back-
ground (value of the pixel: 0) using Image J and Photoshop Cs2
(Adobe). The density of ﬁbers was obtained from drawings using
the line plot proﬁle tool of ImageJ on lanes of 200 pixels (260 μm)
width covering the vertical extent of the cortex from pia to white
matter. The ﬁber density corresponds to the averaged value of
black and white pixels in a 200 pixel line projected on the vertical
axis along the lane.
BRAIN SLICE PREPARATION AND VIRAL TRANSDUCTION FOR IMAGING
PKA ACTIVITY
Rats were killed by decapitation. Brains were quickly removed and
immersed in ice-cold artiﬁcial cerebrospinal ﬂuid (ACSF) con-
taining (in mM): 126 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 1
MgCl2, 26 NaHCO3, 20 D-glucose, 5 Na pyruvate, 1 kynurenic
acid, and saturated with 5% CO2/95% O2. Parasagittal slices
(300 μm thick) of cortex were cut at an angle of 10◦ using a Leica
VT 1000S Vibratome (Leica). Slices were kept at room tempera-
ture for 30 min in the same solution. Brain slices were placed onto
a millicell-CM membrane (Millipore) with culture medium (50%
minimum essential medium, 50% Hanks’ balanced salt solution,
6.5 g/L glucose, and 100 U/ml penicillin/100 μg/ml streptomycin;
Invitrogen). Transduction was performed by adding ∼5 × 105
particles per slice of sindbis virus encoding the GAkdYmut sen-
sor that reports PKA activation through a reversible increase of
ﬂuorescence intensity (Bonnot et al., 2014). Slices were incubated
overnight at 35◦C in 5% CO2. The next morning, brain slices
were equilibrated in ACSF for 1 h and then placed into the record-
ing chamber and perfused continuously at 2 ml/min with ACSF at
32◦C.Under these conditions, sindbis viral transduction efﬁciently
and selectively targets cortical pyramidal neurons, and leaves their
functional properties essentially unaffected (Drobac et al., 2010;
Hu et al., 2011).
OPTICAL RECORDINGS
Two-photon images were obtained with a custom-built 2-photon
laser scanning microscope as described (Bonnot et al., 2014),
based on an Olympus BX51WI upright microscope (Olympus,
Tokyo, Japan) with ×40 (0.8 NA) or ×60 (0.9 NA) water-
immersion objectives and a titanium:sapphire laser (MaiTai HP;
Spectra Physics, Ellicot City, MD, USA). Two-photon excitation
was performed at 920 nm for GFP. Images were acquired as z
stacks and analyzed using ImageJ (U.S. National Institutes of
Health, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/). Occa-
sional x, y, and z drifts were corrected using custom macros
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developed from ImageJ plugins TurboReg, StackReg (Thevenaz
et al., 1998), MultiStackReg, and Image CorrelationJ (Chinga and
Syverud, 2007). Fluorescence variations were measured at the
soma of pyramidal neurons. Fluorescence intensity of regions of
interest (ROIs) was calculated for each time point from average
intensity projection of 3–5 frames by averaging pixel inten-
sity. Variations of ﬂuorescence intensity in a given ROI were
expressed as the ratio F/F0 and calculated according to the
formula (F − F0)/F0. F corresponds to the ﬂuorescence inten-
sity in the ROI at a given time point, and F0 corresponds to
the mean ﬂuorescence intensity in the same ROI during control
baseline prior to drug application. Pseudocolor hue saturation
value (HSV) encoding of ﬂuorescence intensity was performed
using IGOR Pro (WaveMetrics) custom procedures. Pseudocolor
images were obtained by dividing, pixel-by-pixel a raw ﬂuo-
rescence image F by the F0 image averaged over several time
points prior to drug application. Color coding displays the ratio
F/F0 (in hue) and the ﬂuorescence F (in value). The EC50
for NA and DA were obtained by ﬁtting the values with the
Hill equation using IgorPro6. The same equation was used to
determine the 10–90% rise time of the agonist induced PKA
activation.
DRUGS
All drugs were bath applied. SKF38393, SCH23390; Propranolol,
Yohimbin, CGP20712, and forskolin were purchased from Tocris.
NA,DA, haloperidol, and isoproterenol were from Sigma-Aldrich.
STATISTICS
In this report, N represents the number of animals or brain slices
tested while n represents the number of cells on which measure-
ments were performed. Values are expressed as mean ± SEM.
Statistical signiﬁcance was assessed with Student’s t-test. p value
< 0.05 was considered statistically signiﬁcant.
RESULTS
DISTRIBUTION OF LC AND VTA FIBERS IN THE CEREBRAL CORTEX
In order to compare LC and VTA projections to the rodent cortex,
we selectively expressed GFP in DA or NA neurons using Cre-
dependent viral transduction (see Materials and Methods). DBH-
Cre mice (N = 6) and DAT-Cre mice (N = 6) were injected in the
LC or in the VTA, respectively, with a recombinant pseudovirion
driving GFP expression at the membrane of Cre-positive neurons.
Anti-GFP and anti-TH immunohistochemistry showed that GFP
was widely expressed in the LC of DBH-Cre mice and in the VTA
and substantia nigra of DAT-Cremice following viral transduction
(Figure 1A). In LC-injectedDBH-Cremice, 83.9± 2.7% (n= 227;
N = 5) of TH-positive neurons in the LC expressed GFP. Similarly,
86.1 ± 1.2% (n = 158; N = 3) of TH-positive neurons in the VTA
co-expressed GFP. Conversely, LC neurons of VTA-injected DAT-
Cre mice and VTA neurons of LC-injected DBH-Cre mice were
GFP-negative (Figure 1A). These results show that the present
protocol of conditional viral transduction enabled efﬁcient site-
and cell-type-speciﬁc GFP expression in LC NA neurons or VTA
DA neurons. We next examined the distribution of NA and DA
ﬁbers in the cerebral cortex. GFP labeling revealed a high density
of NA ﬁbers throughout all cortical regions and layers examined
(Figures 1B,C). Quantiﬁcation of NA ﬁbers (see Materials and
Methods) revealed moderate laminar and regional differences,
such as an overall lower density in frontal than other regions and
a higher density in upper layers in cingulate, somatosensory, rhi-
nal, and visual than in other layers of these regions (Figure 2).
Similar results were obtained on six LC-injected DBH-Cre mice.
DA ﬁbers had a more contrasted distribution. The highest den-
sity of ﬁbers was observed in a medial rostro-caudal band that
comprised all layers of the prelimbic cortex and extended cau-
dally to the cingulated cortex, but did not reach the retrosplenial
occipital area (Figures 1D and 2). A lateral rostro-caudal band
of lower ﬁber density comprised all layers of the lateral part of
the frontal association cortex, of the agranular insular cortex and
of the rhinal occipital area. Between these two bands, DA ﬁbers
were restricted to deep layers in a large region extending from the
medial part of the frontal association to the visual cortex through
the somatosensory area (Figures 1D and 2). Similar results were
obtained on six VTA-injected DAT-Cre mice. The striatum con-
tained a dense network of DA ﬁbers but was sparsely innervated
by NA ﬁbers (Figures 1C,D), as expected from their known dis-
tributions (Aston-Jones, 2004; Gerfen, 2004). These data conﬁrm
that NA ﬁbers widely innervate the cortical mantle, whereas the
distribution of DA ﬁbers is more restricted and exhibits area and
layer speciﬁcity.
NA AND DA RECEPTORS ARE CO-EXPRESSED AND MEDIATE PKA
ACTIVATION IN CORTICAL PYRAMIDAL NEURONS
We examined responses of cortical neurons to NA, DA or spe-
ciﬁc receptor agonists in frontal, parietal, and occipital areas
where DA ﬁbers are restricted to deep layers (i.e., lateral frontal,
somato-sensory, and visual cortices; see above). We used 2-photon
imaging to monitor responses of layers II/III and V pyramidal
neurons expressing the PKA sensor GAkdYmut (Bonnot et al.,
2014) following sindbis viral transfer in acute rat brain slices
(see Materials and Methods and Drobac et al., 2010; Hu et al.,
2011). Response amplitudes measured at the soma were normal-
ized to those elicited by a maximally effective concentration of
the adenylate cyclase activator forskolin (FSK, 12 μM; Gervasi
et al., 2007). As illustrated in Figure 3, successive bath applica-
tion of DA (10 μM) and NA (10 μM) triggered PKA activation
in most pyramidal neurons of the parietal cortex, showing that
DA and NA receptors can be co-expressed in individual neu-
rons. To estimate the proportion of responsive cells, we arbitrarily
deﬁned a threshold at 5% of the maximal ﬂuorescence variation
obtained with FSK. Using this criterion, we found that virtually
all pyramidal neurons responded to NA (n = 45, N = 2) and
among those, 83 ± 4% responded to DA (39 out of 45 cells).
These effects were mimicked by bath application of the D1/D5
agonist SKF38393 (1 μM) or the beta adrenoceptor agonist iso-
proterenol (1 μM; Figure 3). We found that 97% of the cells
(57 out of 59) responded to isoproterenol and 75% to SKF (44
out of 59), suggesting that most pyramidal neurons co-express
D1/D5 and beta-adrenergic receptors. Dose–response relation-
ships of normalized NA and DA effects showed that NA was
more potent than DA in activating PKA (Figure 3). Indeed, the
EC50 of NA responses was estimated at 25 ± 2 nM and that of
DA at 460 ± 30 nM from the ﬁt of their dose–response curves
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FIGURE 1 | Catecholaminergic projections to the cortex. (A) Immuno-
labeling against TH and GFP in the LC and VTA 8 weeks after bilateral injection
of a Cre-dependent AAV expressing GFP in the LC of DBH-Cre mice or the
VTA of DAT-Cre mice. Note that GFP labeling in VTA-injected DAT-Cre mice
extends to neighbor DA neurons of the substantia nigra pars compacta (SNc)
but is absent from NA neurons of the LC. (B) Immunolabeling of GFP-
expressing ﬁbers in the somato-sensory parietal cortex of DBH-Cre and
DAT-Cre mice. (C,D) Drawings of NA or DA ﬁbers obtained from
immunolabeling of GFP positive ﬁbers in coronal brain sections of LC-injected
DBH-Cre and VTA-injected DAT-Cre mice (antero-posterior from left to right).
Note the different distribution of NA and DA ﬁbers in cortical areas and
caudate-putamen (CPu). Ai: agranular insular cortex; Au: auditory cortex; Cg:
cingulate cortex; DLO: dorso-lateral orbital cortex; FrA: frontal association
cortex; M1-M2-M: primary or secondary motor cortex; MO: medial orbital
cortex; Pir: piriform cortex; PrL: prelimbic cortex; Rh: rhinal cortex; RS:
retrosplenial cortex; S1: primary somatosensory cortex; V: visual cortex.
(see Materials and Methods). Furthermore, maximal responses to
NA and DA were 60 ± 1% and 47 ± 2% of the FSK response,
respectively.
NA AND DA ACTIVATE PKA ACROSS CORTICAL REGIONS AND LAYERS
We next compared PKA activation elicited by DA, NA, SKF38393,
and isoproterenol in layers II/III and V of frontal, parietal, and
occipital cortices (Figure 4 and Table 1). The mean amplitude
of NA responses varied between 54 ± 4% in occipital layer V
(n = 43; N = 4) and 75 ± 4% of the FSK effect in frontal layer
II/III (n = 37, N = 2). Isoproterenol-induced responses varied
similarly between 44 ± 3% in frontal layer V (n = 50, N = 4)
and 56 ± 2% of the FSK effect in frontal layer II/III (n = 76,
N = 4). DA and SKF38393 both caused PKA activation in all
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FIGURE 2 | Density of noradrenergic and dopaminergic fibers in various
areas of the cortex.The density of ﬁbers was obtained from the drawings
shown in Figure 1 on lanes of 200 pixels (260 μm) width orthogonal to the
pial surface, as depicted in images of the upper panel (gray bars). The ﬁber
density, measured in three regions of anterior (A), intermediate (B), and
posterieor (C) coronal brain sections, corresponds to the averaged pixel value
along the lane plotted on the x-axis of the graphs from the pial surface to
indicated depths. NA ﬁbers are widespread in the cortex and are enriched
(arrows) in upper layers of cingulated (Cg), somato-sensory (S), visual (V), and
rhinal (Rh) cortices. Note that DA ﬁbers are absent from most layers of a
rostro-caudal band comprising the medio-lateral part of the frontal association
(FrA), S and V cortices, except for a thin lamina in deep layers.
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FIGURE 3 | Continued
FIGURE 3 | Continued
NA and DA activate the cAMP/PKA pathway in pyramidal neurons.
2-photon imaging of pyramidal neurons expressing the GAkdYmut
ﬂuorescent PKA sensor in parietal cortical slices. (A) Responses to bath
application of DA, NA, and the adenylate cyclase activator FSK. Traces show
the variation of ﬂuorescence intensity measured at the soma of individual
neurons indicated by arrows on pseudocolor images below. Black
arrowheads indicate time points corresponding to pseudocolor images.
(B) Responses to the D1/D5 agonist SKF38393 and the non-speciﬁc beta
adrenergic agonist isoproterenol. (C) Dose–response curves of PKA
activation by NA and DA. Each data point corresponds to the mean
response measured in 10–140 individual neurons from 2 to 10 different brain
slices. Curves were obtained by ﬁtting the values with the Hill equation. NA
was more potent than DA in activating PKA.
areas examined but responses were smaller than those elicited by
NA or isoproterenol (Figure 4A and Table 1). DA responses were
signiﬁcantly smaller in both layers of the frontal cortex than in
more caudal regions. Indeed, DA responses in layer II/III were
46 ± 4% in occipital (n = 38, N = 2) and 33 ± 3% of the FSK
effect in the frontal cortex (n = 39, N = 3, p = 0.006). Simi-
larly, DA responses in layer V were 44 ± 4% in occipital (n = 37,
N = 3) and 29 ± 2% of the FSK effect in the frontal cortex (n = 44,
N = 3, p = 0.01). Similar results were obtained with the D1/D5
agonist SKF38393, although amplitudes were smaller than those
obtained with DA (Figure 4A and Table 1, p = 0.04 in layer II/III
and p = 0.02 in layer V). We also observed that less than 5% of
the recorded pyramidal neurons were unresponsive to NA or iso-
proterenol, regardless of the layer or cortical region examined. For
DA, a similar result was obtained in layer II/III. However, the pro-
portion of unresponsive cells was higher in layer V and reached
12% in the parietal cortex. For SFK38393, the proportion of unre-
sponsive cells was above 5% in all cases with more unresponsive
cells in layer V than in layer II/III. The highest value was observed
in layer V of the parietal cortex with 27% of recorded neurons not
responding to SFK38393. These results indicate that NA and iso-
proterenol induce overall larger and more homogeneous cortical
responses than DA and SKF38393, whose effects increased along
the antero-posterior axis.
We also examined the onset kinetics of PKA responses by deter-
mining their 10–90% rise time (Figure 4B and Table 1). Kinetics
of NA and isoproterenol responses exhibited moderate regional
differences. Conversely, DA and SKF38393 response onsets were
faster in occipital than in frontal regions with intermediate val-
ues in the parietal cortex. This was observed in both layers II/III
and V (0.01 < p ≤ 0.003 for DA, p < 0.001 for SKF). As a
consequence of these regional variations, the onset kinetics of
DA-receptor mediated responses were markedly slower than those
of NA-receptor mediated responses in the frontal cortex, but
were comparable in the occipital cortex. These results conﬁrm
that NA and isoproterenol induce overall more homogeneous
cortical responses and indicate that DA and SKF38393 effects
increase in amplitude and velocity along the antero-posterior
axis.
CORTICAL EFFECTS OF NA AND DA INVOLVE BOTH Gs- AND
Gi-COUPLED RECEPTORS
Gs-coupled NA and DA receptors involved in PKA activation were
characterized in parieto-cortical layer II/III pyramidal neurons
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FIGURE 4 | NA and DA activate PKA across cortical regions and layers.
Data were obtained by 2-photon imaging of PKA activity in pyramidal neurons
as illustrated in Figure 3. Imaging was performed in frontal, parietal, and
occipital regions of parasagittal slices of the medio-lateral cortex that exhibits
scarce DA ﬁbers restricted to deep layers. (A) Amplitude of ﬂuorescence
variations normalized to the response to FSK. (B) Onset kinetics of responses
was analyzed by calculating the 10–90% rise time. Tables indicate signiﬁcant
(s) or non-signiﬁcant (ns) differences between values measured in the areas
(F-P: frontal vs. parietal; P-O: parietal vs. occipital; F-O: frontal vs. occipital).
Note the antero-posterior gradient of DA responses amplitude and velocity.
Table 1 | NA and DA activate PKA across cortical region and layers.
Frontal Parietal Occipital
Drugs (n/N) Layer Amplitude (% FSK) T10–90% (s) Amplitude (% FSK) T10–90% (s) Amplitude (% FSK) T10–90% (s)
DA II/III 32.5 ± 3.3 (39/3) 109.9 ± 14.1 (22/3) 49.5 ± 1.8 (242/12) 110.5 ± 4.8 (181/12) 46.4 ± 3.9 (38/2) 61.7 ± 7.1 (27/2)
V 28.5 ± 2.4 (44/3) 170.0 ± 13.1 (30/3) 33.7 ± 3.1 (105/6) 143.4 ± 11.9 (53/6) 44.1 ± 3.8 (37/3) 119.3 ± 14.0 (37/3)
NA II/III 74.5 ± 3.7 (37/2) 57.8 ± 3.0 (32/2) 61.9 ± 2.9 (114/7) 74.3 ± 2.0 (84/7) 61.3 ± 2.5 (77/2) 53.3 ± 2.8 (62/2)
V 57.6 ± 3.5 (26/3) 90.2 ± 4.9 (21/3) 72.5 ± 5.0 (29/2) 48.8 ± 2.8 (26/2) 53.9 ± 3.5 (43/4) 68.4 ± 3.2 (35/4)
SKF II/III 21.1 ± 3.4 (31/4) 147.4 ± 9.9 (39/4) 19.9 ± 1.4 (196/10) 134.9 ± 7.9 (81/10) 34.5 ± 2.6 (40/4) 55.2 ± 3.4 (31/3)
V 22.0 ± 3.6 (36/4) 192.4 ± 20.2 (24/3) 31.4 ± 3.8 (60/4) 106.3 ± 8.9 (32/4) 32.9 ± 2.8 (69/5) 64.6 ± 5.9 (28/3)
ISO II/III 55.8 ± 2.0 (76/4) 69.2 ± 3.5 (70/4) 48.1 ± 1.5 (172/7) 45.7 ± 1.2 (98/7) 52.3 ± 3.1 (40/3) 47.5 ± 2.5 (32/3)
V 43.5 ± 2.5 (50/4) 54.0 ± 3.8 (46/4) 48.9 ± 3.8 (60/4) 65.9 ± 4.1 (47/4) 46.8 ± 2.1 (135/5) 62.7 ± 4.3 (50/5)
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using speciﬁc antagonists (Figure 5 and Table 2). The non-
selective beta-adrenergic receptor antagonist propranolol (50 μM,
N = 2, n = 22) and the speciﬁc beta1 antagonist CGP20712
(100 nM, N = 3, n = 40) reduced PKA activation by NA (10 μM)
by more than 90% (Figure 5). Responses to isoproterenol (1 μM)
were also reduced by propranolol to a similar extent (Table 2).
These results indicate that NA-induced PKA activation in corti-
cal pyramidal neurons is primarily mediated by beta1-adrenergic
receptors. Responses to DA (10 μM) and to SKF38393 (1 μM)
were almost abolished in the presence of the D1/D5 receptor
antagonist SCH23390 (1 μM; Table 2). These results indicate
that DA-induced PKA activation in cortical pyramidal neurons
is mediated by D1/D5 receptors. NA and isoproterenol responses
were not signiﬁcantly altered by the D1/D5 antagonist SCH23390
(1 μM), showing that NA effects did not involve DA receptors.
Surprisingly, we found that responses to DA and SKF38393 were
FIGURE 5 | NA and DA receptors involved in PKA activation. Graphs show
the effects of antagonists propranolol (beta adrenergic), CGP20712
(beta1-speciﬁc) and SCH23390 (D1/D5) on responses to NA and DA of layer
II/III pyramidal neurons of the parietal cortex. Gray traces correspond to the
ﬂuorescence intensity normalized to the baseline value measured on
individual neurons expressing the PKA sensor in parietal cortical slices
(averaged traces are in black). Histograms summarize the effects of these
antagonists on responses to NA, DA, the beta adrenergic agonist
isoproterenol and the D1/D5 agonist SKF38393. ND: not determined; but
Castro et al. (2010) reported inhibition of isoproterenol responses in cortical
pyramidal neurons by CGP20712 in similar experimental conditions. Values
represent the mean response of 20–200 neurons recorded in 2–12 different
brain slices. Statistical signiﬁcance relative to control responses is indicated
by an asterisk. Note that DA responses were prevented by both beta
adrenergic antagonists whereas NA responses were insensitive to the D1/D5
antagonist.
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Table 2 | PKA stimulation involves beta1 adrenergic and D1/D5 dopaminergic receptors.
NAAmplitude (% FSK) ISOAmplitude (% FSK) DAAmplitude (% FSK) SKF Amplitude (% FSK)
Control (n/N) 61.9 ± 2.9 (114/7) 48.1 ± 1.5 (172/7) 49.5 ± 1.8 (242/12) 19.9 ± 1.4 (196/10)
SCH23390 (n/N) 51.8 ± 3.9 (56/2) 60.5 ± 2.3 (66/2) 3.5 ± 1.4 (56/2) 4.0 ± 0.1(49/4)
Propranolol (n/N) 6.0 ± 0.7 (22/2) 4.1 ± 0.8 (21/2) 9.7 ± 1.3 (57/2) 8.5 ± 2.1(24/2)
CGP20712 (n/N) 8.8 ± 1.9 (40/3) ND 11.0 ± 2.7 (54/2) 11.3 ± 1.2 (101/3)
inhibited by beta adrenergic antagonists. Indeed, propranolol and
CGP20712 similarly reduced responses to DA (10 μM) by ∼80%
and responses to SKF38393 (1 μM) by ∼50% (Figure 4 and
Table 2), suggesting that DA effects may involve beta1-D1/D5
heteromeric receptors.
We next examined the contribution of Gi-coupled receptors
in the response of parieto-cortical layer II/III pyramidal neurons
to NA and DA (Figure 6 and Table 3). Inhibition of the alpha2
adrenoceptor by yohimbin (1 μM) signiﬁcantly increased the
mean amplitude of theNA response by 17% (p = 0.007). Similarly,
the D2-like receptors antagonist haloperidol (1 μM) signiﬁcantly
increased the DA response by 30% (p < 0.001). Haloperidol and
yohimbin also increased the velocity of DA and NA responses.
Indeed, in the presence of haloperidol, the 10–90% rise time of
DA responses decreased signiﬁcantly from 111 ± 5 s (n = 181,
N = 12) to 76 ± 3 s (n = 84, N = 4, p < 0.001). Yohimbin appli-
cation similarly resulted in a decreased rise time of NA responses
from 74 ± 2 (n = 84, N = 7) to 47 ± 2 s (n = 119, N = 5;
p < 0.001; Figure 6 and Table 3). We previously noted a large het-
erogeneity in the amplitudes of DA responses (Figures 3 and 5).
We thus examined whether antagonists of Gi-coupled receptors
could modify the distribution of DA and NA response amplitudes
(Figures 6B,C). The plot of DA response amplitudes in control
condition had a broad distribution, with almost half of the cells
exhibiting responses below 40% of the FSK effect, and only 6%
responding above 90%. The distribution of DA response ampli-
tudes was shifted to higher values in the presence of haloperidol,
with only 10% of the cells responding below 40% of the FSK
effect, and 22% responding above 90%. Although NA response
amplitudes were less variable, yohimbine also markedly shifted
their distribution toward higher values. These results indicate that
Gi-coupled receptors are co-activated with Gs-coupled receptors
by DA and NA, and signiﬁcantly limit DA- and NA-induced PKA
activation in cortical pyramidal neurons.
DISCUSSION
Genetic labeling conﬁrmed that NA neurons innervate the entire
cortex whereas DA ﬁbers were present in all layers of restricted
medial and lateral cortical areas but only in deep layers of other
areas. Imaging of PKA activity in frontal, parietal, and occipital
regions with scarce DA ﬁbers revealed that layers II/III andV pyra-
midal neurons widely respond to NA and DA. The EC50 of NA
response was more than 10-fold lower than for DA. Responses to
NA and isoproterenol had higher amplitude, velocity and were
more homogeneous than those elicited by DA and SKF38393,
whose amplitude and velocity increased along the antero-posterior
axis. NA- and DA-induced PKA activation was mediated by Gs-
coupled beta1 and D1/D5 receptors. Beta adrenergic antagonists
inhibited both NA and DA responses whereas the effect of a
D1/D5 antagonist was selective of DA responses. NA and DA
responses also involved Gi-coupled alpha2 adrenergic and D2-
like dopaminergic receptors that markedly reduced the amplitude
and velocity of responses and contributed to their cell-to-cell
heterogeneity.
DISTRIBUTION OF CATECHOLAMINERGIC FIBERS IN THE CORTEX
The overall distribution of GFP-labeled DA and NA ﬁbers in
the cortex we describe is largely congruent with previous maps
obtained using histochemistry, radiolabeling or immunohisto-
chemical approaches (Morrison et al., 1978, 1979; Descarries et al.,
1987; Berger et al., 1991; Nicholas et al., 1996; Venkatesan et al.,
1996; Latsari et al., 2002; Papay et al., 2006; Paschalis et al., 2009).
NA ﬁbers were present in all layers and areas of the cortex,
although their density exhibited regional and laminar variations.
Conversely, DA ﬁbers were present in all layers of two medial
and lateral rostro-caudal bands comprising frontal, cingulated,
rhinal cortices as well as the agranular area of the insular cor-
tex but were conﬁned to deep layers of other cortical areas. The
present study shows that DA receptors are functionally expressed
in areas with scarce or no DA ﬁbers, consistent with the pres-
ence of their cognate mRNAs and proteins (Ariano and Sibley,
1994; Khan et al., 1998; Luedtke et al., 1999; Lemberger et al., 2007;
Rivera et al., 2008; Oda et al., 2010). The source and nature of the
endogenous ligand activating theseDA receptors is still unclear but
several studies indicate that DA can be co-released from NA ﬁbers
where it is present as the biosynthetic precursor of NA. Indeed,
Table 3 | NA and DA effects involve alpha2 adrenergic and D2-like dopaminergic receptors.
DA DA + Haloperidol NA NA +Yohimbin
Amplitude (% FSK) (n/N) 49.5 ± 1.8 (242/12) 69.7 ± 1.9 (143/6) 61.9 ± 2.9 (114/7) 72.3 ± 1.7 (133/6)
T10−90% (s) (n/N) 110.5 ± 4.8 (181/12) 75.9 ± 3.0 (84/4) 74.3 ± 2.0 (84/7) 46.8 ± 1.9 (119/5)
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FIGURE 6 | Gi-coupled receptors dampen NA- and DA-induced PKA
activation. (A) Mean amplitude and rise time of NA- and DA-induced
(10 μM each) PKA activation measured on layer II/III pyramidal neurons of
the parietal cortex in the absence or presence of the D2-like antagonist
haloperidol (1 μM) or the alpha2 adrenergic antagonist yohimbin (1 μM).
(B,C) Distribution of FSK-normalized DA or NA response amplitudes
measured in the same sample of neurons as in (A) in absence or presence
of haloperidol or yohimbin. The left axis corresponds to the histogram of the
proportion of cells for each amplitude interval and the right axis to the curve
of cumulated frequency over the amplitude intervals. Note the shift of NA
and DA response amplitude distributions toward higher amplitudes in the
presence of antagonists of Gi-coupled receptors.
Devoto et al. (2005, 2008) showed that electrical stimulation of
the LC results in VTA-independent NA and DA increases in the
frontal cortex but also in cortices devoid of DA ﬁbers. Similar
conclusions were drawn from a study of amphetamine-induced
DA release in the dorsal hippocampus, which is prevented by
TH knock-down using siRNAs in the LC but not in the VTA
(Smith and Greene, 2012). Hence, LC ﬁbers are a plausible source
of endogenous DA that provides a rationale for the widespread
functional expression of Gs- and Gi-coupled DA receptors in the
cortex.
NA AND DA RECEPTORS WIDELY ACTIVATE cAMP/PKA IN THE CORTEX
Our results indicate that NA and DA receptors mediate activa-
tion of the cAMP/PKA pathway in pyramidal neurons throughout
the cortex, even in areas with scarce or no DA ﬁbers. Indeed,
we observed robust PKA activation by NA and DA in layer
II/III of fronto-lateral, parietal and occipital regions of the
cortex where DA ﬁbers are restricted to deep layers. These
results indicate that NA released by LC ﬁbers widely inﬂuences
the function of neural networks in the entire cortical mantle.
The same conclusion applies to DA, regardless of its source.
We found that NA responses were generally larger, with faster
onsets and exhibited less regional variability than DA responses.
NA-induced PKA activation was mimicked by the beta agonist
isoproterenol and primarily mediated by beta 1 receptors, as
shown by the powerful inhibitory effect of the speciﬁc antag-
onist CGP20712 on NA responses. These results are consistent
with the predominant expression of beta1 over beta2–3 recep-
tors in the cortex and with the widespread expression of beta1
receptors in layers and areas of the rodent cortex (Nicholas et al.,
1996; Paschalis et al., 2009). DA-induced PKA activation exhib-
ited similar properties in layer II/III and layer V, but both the
amplitude and velocity of DA responses increased from ros-
tral to caudal regions. DA responses were mimicked by the
D1/D5 agonist SKF38393 and prevented by the D1/D5 recep-
tor antagonist SCH23390, pointing to the involvement of D1
and/or D5 receptors in DA-induced PKA activation and its ros-
trocaudal variations. Regional and laminar differences of D1
and D5 expression levels have been reported in the rodent cor-
tex (Ariano and Sibley, 1994; Ciliax et al., 2000). However, the
lack of speciﬁc pharmacological tools differentiating these recep-
tors makes it difﬁcult to assign the present functional variations
to the regional levels of these receptors. The possibility that
D1/D5 receptors forms heteromers with beta1 adrenoceptors
further complicates the interpretation of DA response regional
variations.
We found that the beta blocker propranolol and the beta1
antagonist CGP20712 inhibited NA responses. Surprisingly, these
antagonists also prevented DA responses and largely reduced
SKF38393 responses suggesting that DA-induced PKA activation
in the cortex may involve beta1 adrenergic receptors. Previ-
ous studies established that DA effects can occur through the
activation of adrenergic receptors (Aguayo and Grossie, 1994;
Rey et al., 2001; Cornil et al., 2002). The present observa-
tions that DA effects were mimicked by SKF38393 and that
response to these agonists were prevented by the D1/D5 antag-
onist SCH23390 imply a direct effect of DA through D1/D5,
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but not beta adrenergic receptors. DA receptors are known
to form heteromers with a variety of receptors including beta
adrenoceptors (Rebois et al., 2012; Fuxe et al., 2014). Moreover,
cross antagonism by speciﬁc antagonist has been demonstrated
for the beta1-D4 receptor heteromer (Gonzalez et al., 2012).
Hence, these reports substantiate the hypothesis that D1/D5
receptors exist as heteromers with beta1 adrenoceptors in the
cortex, thus exhibiting the speciﬁc pharmacological pattern we
observed.
NA AND DA CONTROL CORTICAL cAMP/PKA SIGNALING VIA Gs- and
Gi-COUPLED RECEPTORS
Our results indicate that DA and NA exert a balanced control
on cortical cAMP/PKA signaling by activating both Gs- and Gi-
coupled receptors. We found that Gs-coupled beta1 and D1/D5
receptors are co-expressed in virtually all layers II/III and V pyra-
midal neurons throughout the antero-posterior axis of the cortex.
The effects of yohimbin and haloperidol on NA and DA response
in pyramidal neurons of parietal layer II/III suggest that alpha2
adrenoceptors and D2-like receptors are also broadly expressed
in the cortex. This is in agreement with previous reports show-
ing widespread immunoreactivity for alpha2 and D4 receptors
in the cortex (Venkatesan et al., 1996; Khan et al., 1998; Rivera
et al., 2008) and for D2 receptors in pyramidal cells of the medial
prefrontal cortex (Zhang et al., 2010).
We showed that kinetics and amplitudes of catecholaminer-
gic signals vary between cortical areas. It was previously shown
in pyramidal neurons of the prefrontal cortex that intracellular
elements of the cAMP/PKA cascade, such as phosphodiesterases,
phosphatases, or the coupling between receptor and adenylate
cyclases are essential in controlling the kinetics and shape of
D1-like responses (Castro et al., 2013).
We found that block of alpha2 adrenoreceptors and D2-like
receptors by yohimbin and haloperidol increased the amplitude
and velocity of NA and DA responses. This is consistent with an
inhibitory effect of these receptors on cAMP/PKA signaling that
limits DA- and NA-induced PKA activation in cortical pyramidal
neurons. In the case of DA, the balance of Gs- and Gi-coupled
receptors effects was such that many cells were not responsive
to a saturating DA concentration. Hence, regulation of the bal-
ance between Gs- and Gi-coupled receptor activities can largely
inﬂuence the net effect of catecholamines on cortical neurons and
networks. Interestingly, DA levels in basal conditions or upon
LC stimulation are comparable to those of NA in various corti-
cal regions, but markedly lower than DA levels in basal ganglia
(Devoto et al., 2005, 2008). Our measurements of EC50 values are
indicative of a ∼20-fold lower afﬁnity of DA for D1/D5 recep-
tors than of NA for beta1 receptors, while NA and DA Gi-coupled
receptors exhibit higher afﬁnities than their cognate Gs-coupled
receptors (for a detailed comparison of pharmacological proper-
ties of receptors, see the International Union of Basic and Clinical
Pharmacology database: http://www.guidetopharmacology.org/).
This suggests that, at low catecholamine concentration, DA may
essentially trigger cAMP/PKA inhibition whereas NA effects may
be more balanced. Conversely, large catecholamine increases may
be required for a signiﬁcant contribution of DA to cAMP/PKA
stimulation. Assuming co-release of NA and DA from LC ﬁbers in
the cortex, DA may thus expand the dynamic range of LC effects
on cortical cAMP/PKA signaling.
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